Phase I Clinical Trials
Europe's Premier Early Phase Clinical Trials Meeting
Informa Life Sciences’ annual Phase I Clinical Trials will deliver expert strategies and practical industry solutions to optimise your early stage drug development.
Last year's speakers included European Regulatory Authorties and over 50 senior speakers from large and small pharma and biotechs.
2010 Conference Highlights
- European regulatory updates on early phase trials
- Safety in early clinical development – including renal, hepatic, cardiac, CNS, reprotox and immunotox
- Innovation in early phase studies
- Modelling, simulation and statistical analysis
- Biomarkers for predictivity
- Practical, real-life examples of trial design
- Translation from Preclinical to Early Clinical and from Early Clinical to Late Phase
- Cost considerations in early phase trials
Expert Speaker Pannel
The agenda for this event is currently under development - if you would like to offer any suggestions for topic ideas and themes, or to suggest conference speakers please contact Sarah Palit
Email: sarah.palit@informa.com
Telephone: +44 (0)20 7017 5371
Dates and Venues
14 Feb 2011 - 18 Feb 2011
Park Plaza Victoria London
Testimonials from Phase I 2010
"Very good conference - recent, state-of-art"
"Well organised, good quality speakers"
"Informative speakers, interesting interactive sessions, invaluable networking opportunities"
"Highly interactive with hands-on experts - took away really practical tips"
"This is a great event for all industry staff interested in progressing projects from discovery to clinical development and proof of concept. All the technical, regulatory and innovative solutions to rapid proof of concept get discussed and debated at this conference."
